Ocular Therapeutix, Inc. (OCUL)
8.22
+0.19
(+2.37%)
USD |
NASDAQ |
May 21, 16:00
8.22
0.00 (0.00%)
After-Hours: 19:59
Ocular Therapeutix Research and Development Expense (TTM) : 220.45M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EyePoint, Inc. | 234.61M |
| Merck & Co., Inc. | 21.57B |
| Zevra Therapeutics, Inc. | 13.78M |
| Axsome Therapeutics, Inc. | 190.82M |
| Bristol Myers Squibb Co. | 9.494B |